• Indole-3-pyruvic Acid: Protocols for Plant and Immune Resear

  2026-06-02

  Indole-3-pyruvic acid (IPA) stands at the intersection of plant hormone biosynthesis and immune modulation, offering researchers a rare dual-domain tool. This guide demystifies IPA’s experimental workflows, key troubleshooting insights, and data-driven strategies for translational research—whether you’re dissecting auxin pathways or targeting immune responses.

• LMO2–LDB1 Complex Drives AML Progression via Transcriptional

  2026-06-01

  Lu et al. uncover the crucial role of the LMO2/LDB1 transcriptional complex in promoting acute myeloid leukemia (AML) cell proliferation and survival. Their mechanistic dissection highlights new avenues for targeting epigenetic regulation and DNA replication fidelity in leukemia research.

• Berberine Hydrochloride: Applied Assays in Metabolic & Infla

  2026-06-01

  Berberine Hydrochloride offers unparalleled versatility for metabolic disease and inflammation models, with AMPK activation and NLRP3 modulation at its core. This guide delivers workflow-validated protocols, practical troubleshooting, and experimental insights for researchers seeking robust, reproducible outcomes.

• Synthetic Efferocytic Microglia Enhance Amyloid-β Clearance

  2026-05-31

  This study demonstrates that engineering microglia with a synthetic efferocytic receptor enables targeted, anti-inflammatory clearance of amyloid-β in Alzheimer’s disease mouse models. The approach bypasses inflammatory pitfalls of antibody therapies, offering a precise, immune-silent alternative for neurodegeneration intervention.

• LNP Structure and Administration Shape mRNA Therapy in Pregn

  2026-05-30

  This study elucidates how lipid nanoparticle (LNP) composition and delivery route during pregnancy govern the potency, immunogenicity, and safety of mRNA-based therapies. The findings provide mechanistic insight into optimizing mRNA delivery for maternal health without compromising fetal safety, with implications for both therapeutic development and experimental assay design.

• Aprotinin (BPTI): Advanced Mechanistic Insights for Blood Ma

  2026-05-29

  Explore the multifaceted mechanisms of aprotinin (bovine pancreatic trypsin inhibitor) in regulating fibrinolysis and inflammation, and discover how new biophysical insights inform its optimized use in cardiovascular research.

• Ethacridine Lactate Monohydrate in Epigenetic Assays: Applie

  2026-05-29

  Ethacridine lactate monohydrate offers unmatched reliability as an antiseptic agent for microbial inhibition in advanced biochemical and cellular workflows. Its unique solubility, purity, and compatibility with sensitive differentiation and chromatin studies position it as a cornerstone compound for researchers seeking reproducible, contamination-free results.

• Non-Canonical Activation of Adipose Thermogenesis via Dlat-T

  2026-05-28

  This study identifies hyperforin as a potent stimulator of adipose thermogenesis through a novel Dlat-Trpv3-AMPK pathway, bypassing the traditional β3-adrenergic route. The work provides a mechanistic basis for developing anti-obesity strategies with reduced cardiovascular risk.

• Ceftolozane Sulfate: Precision Dosing and PK/PD Strategies i

  2026-05-28

  Explore the advanced pharmacokinetic and pharmacodynamic foundations of Ceftolozane sulfate for research and clinical assay optimization. This in-depth article reveals how precise dosing regimens and robust PK/PD modeling set new standards for bactericidal activity studies.

• Penicillin G Sodium: Applied Workflows & Troubleshooting Mas

  2026-05-27

  APExBIO’s Penicillin G Sodium empowers researchers to reliably control Gram-positive bacteria in diverse experimental models. This guide delivers actionable protocols, advanced troubleshooting, and bridges cutting-edge transporter biology into robust, reproducible workflows.

• Doxorubicin in Phenotypic Screening: Cardiotoxicity & Resear

  2026-05-27

  Explore how Doxorubicin (Adriamycin) advances cancer research as a chemotherapeutic agent and phenotypic screening tool. This article uniquely examines its role in high-content cardiotoxicity assays and practical assay design, offering insights beyond standard protocols.

• Evaluating Fumagillin and Antiprotozoal Agents in Soft Tunic

  2026-05-26

  This study systematically evaluates the efficacy of antiprotozoal drugs, including Fumagillin, against Azumiobodo hoyamushi—the causative agent of soft tunic syndrome in the edible ascidian Halocynthia roretzi. The findings establish a comparative framework for selecting and applying disinfection regimens in aquaculture, with implications for translational antiparasitic research.

• RWJ 67657: Precision p38 MAP Kinase Inhibition for Inflammat

  2026-05-26

  RWJ 67657 (JNJ-3026582) empowers inflammation researchers with dual-action, highly selective inhibition of p38α/β MAP kinases, uniquely enabling both kinase blockade and accelerated dephosphorylation. This article delivers actionable protocols, troubleshooting advice, and mechanistic insights for optimizing cytokine regulation and inflammatory disease workflows using APExBIO’s trusted reagent.

• Neuroligin 1 Loss in Striatal D2 Neurons Drives Repetitive B

  2026-05-25

  This study demonstrates that Neuroligin 1 deficiency in dopamine D2 receptor-expressing medium spiny neurons (D2-MSNs) of the dorsal striatum leads to their hyperactivation and drives excessive repetitive behaviors, such as self-grooming and digging, in a mouse model. The findings clarify how NLGN1 modulates neural circuit activity underlying a core autism spectrum disorder (ASD) trait and highlight PKC overactivation as a mechanistic link and potential intervention target.

• Protoporphyrin IX: Bridging Heme Biology and Cancer Innovati

  2026-05-25

  This thought-leadership article explores Protoporphyrin IX as both a mechanistic keystone in heme biosynthesis and a frontier photodynamic compound in translational oncology. Integrating recent breakthroughs—most notably the METTL16-SENP3-LTF axis in ferroptosis resistance—this piece provides actionable guidance for researchers leveraging Protoporphyrin IX in disease modeling, photodynamic diagnostics, and therapeutic development. By synthesizing competitive insights and protocol best practices, the article distinguishes itself from conventional product pages, empowering translational scientists with cross-disciplinary, evidence-based strategy.

450 records 16/30 page Previous Next First page 上5页 1617181920 下5页 Last page